The Latest Breaking News from XLV

Agilent Technologies has underperformed the healthcare sector lately, and analysts are moderately optimistic about the stock’s potential.

Cencora has outperformed other healthcare stocks over the past year and analysts remain bullish about the stock’s prospects.

Despite Stryker’s outperformance relative to the healthcare sector over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

The healthcare sector is poised for strong growth, driven by ongoing advancements in medical technology, demographic trends, and increased healthcare spending. Thus, to gain exposure to the healthcare sector, one could consider investing in quality ETFs: iShares Global Healthcare (IXJ), Vanguard Health Care (VHT), and Health Care Select Sector SPDR…

Healthcare ETFs offer diversified exposure across resilient subsectors and combine defensive qualities with long-term growth potential. Therefore, investors could consider buying strong healthcare ETFs, such as iShares U.S. Healthcare (IYH), Vanguard Health Care Index Fund (VHT), and The Health Care Select Sector (XLV). Read more….

IDXX Laboratories has recently underperformed the Healthcare sector, but Wall Street analysts are moderately optimistic about the stock’s prospects.

Growing concerns over the possibility of a recession due to high inflation and the Fed’s interest rate hikes are expected to keep the stock market under pressure in the near term. Therefore, investors could hedge their portfolios against the economic downturn by adding quality ETFs Health Care Select Sector SPDR…

The Health Care Select Sector SPDR Fund ETF (NYSE: XLV) has been ripping higher, while the Technology Select Sector SPDR Fund ETF (NYSE: XLK) has been getting crushed.